Benazepril plus amlodipine or hydrochlorothiazide for hypertension

New England Journal of Medicine

Volumn 360, Issue 11, 2009, Pages 1147-1150

  Parra, David ^a   Rosenstein, Robert ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE; CHLORTALIDONE; HYDROCHLOROTHIAZIDE; POTASSIUM; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FUROSEMIDE; RENIN;

HUMAN; HYPERTENSION; HYPOKALEMIA; LETTER; MORTALITY; PRIORITY JOURNAL; BLOOD PRESSURE; DRUG EFFICACY; HIGH RISK PATIENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

EID: 62349109713     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc082725     Document Type: Letter

References (5)

1. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-28.
2. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000;35:1025-30.
3. Bartsch GE, Broste SBC, Grandits GA, Grimm RH, Neaton JD, Svendesn KH. Hydrochlorothiazide, chlorthalidone and mortality in the Multiple Risk Factor Intervention Trial. Circulation 1984;70:Suppl II:II-360. abstract.
4. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990;82: 1616-28.
5. Laragh JH, Lamport B, Sealey J, Alderman MH. Diagnosis ex juvantibus: individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension 1988;12:223-6.